Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 227

1.

Neuropsychiatric lupus: new mechanistic insights and future treatment directions.

Schwartz N, Stock AD, Putterman C.

Nat Rev Rheumatol. 2019 Jan 18. doi: 10.1038/s41584-018-0156-8. [Epub ahead of print] Review.

PMID:
30659245
2.

NF-kB signaling in myeloid cells mediates the pathogenesis of immune-mediated nephritis.

Chalmers SA, Garcia SJ, Reynolds JA, Herlitz L, Putterman C.

J Autoimmun. 2019 Jan 3. pii: S0896-8411(18)30502-X. doi: 10.1016/j.jaut.2018.11.004. [Epub ahead of print]

PMID:
30612857
3.

A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: Predicting changes in disease activity.

Smith EMD, Eleuteri A, Goilav B, Lewandowski L, Phuti A, Rubinstein T, Wahezi D, Jones CA, Marks SD, Corkhill R, Pilkington C, Tullus K, Putterman C, Scott C, Fisher AC, Beresford MW.

Clin Immunol. 2018 Nov 2. pii: S1521-6616(18)30425-X. doi: 10.1016/j.clim.2018.10.021. [Epub ahead of print]

PMID:
30391651
4.

BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.

Chalmers SA, Glynn E, Garcia SJ, Panzenbeck M, Pelletier J, Dimock J, Seccareccia E, Bosanac T, Khalil S, Harcken C, Webb D, Nabozny G, Fine JS, Souza D, Klein E, Herlitz L, Ramanujam M, Putterman C.

Clin Immunol. 2018 Dec;197:205-218. doi: 10.1016/j.clim.2018.10.008. Epub 2018 Oct 16.

PMID:
30339790
5.

Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling.

Mike EV, Makinde HM, Der E, Stock A, Gulinello M, Gadhvi GT, Winter DR, Cuda CM, Putterman C.

Front Immunol. 2018 Sep 26;9:2189. doi: 10.3389/fimmu.2018.02189. eCollection 2018.

6.

The blood-brain barrier, TWEAK, and neuropsychiatric involvement in human systemic lupus erythematosus and primary Sjögren's syndrome.

Lauvsnes MB, Tjensvoll AB, Maroni SS, Kvivik I, Grimstad T, Greve OJ, Harboe E, Gøransson LG, Putterman C, Omdal R.

Lupus. 2018 Nov;27(13):2101-2111. doi: 10.1177/0961203318804895. Epub 2018 Oct 3.

PMID:
30282561
7.

Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus.

Mike EV, Makinde HM, Gulinello M, Vanarsa K, Herlitz L, Gadhvi G, Winter DR, Mohan C, Hanly JG, Mok CC, Cuda CM, Putterman C.

J Autoimmun. 2019 Jan;96:59-73. doi: 10.1016/j.jaut.2018.08.005. Epub 2018 Aug 30.

PMID:
30174216
8.

Methodological considerations in comparing access to Pre-emptive renal transplantation between SLE and other ESRD causes in the USRDS.

Broder A, Mowrey WB, Golestaneh L, Putterman C, Costenbader KH, Kim M.

Semin Arthritis Rheum. 2018 Jun 12. pii: S0049-0172(18)30239-7. doi: 10.1016/j.semarthrit.2018.05.014. [Epub ahead of print]

PMID:
30064728
9.

The Incidence and Prevalence of Adult Primary Sjögren's Syndrome in New York County.

Izmirly PM, Buyon JP, Wan I, Belmont HM, Sahl S, Salmon JE, Askanase A, Bathon JM, Geraldino-Pardilla L, Ali Y, Ginzler EM, Putterman C, Gordon C, Helmick CG, Parton H.

Arthritis Care Res (Hoboken). 2018 Jul 25. doi: 10.1002/acr.23707. [Epub ahead of print]

PMID:
30044541
10.

The SLE-key test serological signature: new insights into the course of lupus.

Putterman C, Pisetsky DS, Petri M, Caricchio R, Wu AHB, Sanz I, Oates JC, Wallace S, Sorek R, Gerwien R, Safer P, Jakobi-Brook K, Cohen IR.

Rheumatology (Oxford). 2018 Sep 1;57(9):1632-1640. doi: 10.1093/rheumatology/key149.

PMID:
29873771
11.

Erythrocyte-bound C4d in combination with complement and autoantibody status for the monitoring of SLE.

Merrill JT, Petri MA, Buyon J, Ramsey-Goldman R, Kalunian K, Putterman C, Conklin J, Furie RA, Dervieux T.

Lupus Sci Med. 2018 May 23;5(1):e000263. doi: 10.1136/lupus-2018-000263. eCollection 2018.

12.

Brief Report: Tubulointerstitial Damage in Lupus Nephritis: A Comparison of the Factors Associated With Tubulointerstitial Inflammation and Renal Scarring.

Londoño Jimenez A, Mowrey WB, Putterman C, Buyon J, Goilav B, Broder A.

Arthritis Rheumatol. 2018 Nov;70(11):1801-1806. doi: 10.1002/art.40575. Epub 2018 Sep 24.

PMID:
29851285
13.

Mechanisms of neuropsychiatric lupus: The relative roles of the blood-cerebrospinal fluid barrier versus blood-brain barrier.

Gelb S, Stock AD, Anzi S, Putterman C, Ben-Zvi A.

J Autoimmun. 2018 Jul;91:34-44. doi: 10.1016/j.jaut.2018.03.001. Epub 2018 Apr 4.

PMID:
29627289
14.

A Distinct T Follicular Helper Cell Subset Infiltrates the Brain in Murine Neuropsychiatric Lupus.

Jain S, Stock A, Macian F, Putterman C.

Front Immunol. 2018 Mar 13;9:487. doi: 10.3389/fimmu.2018.00487. eCollection 2018.

15.

Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus.

Chalmers SA, Wen J, Doerner J, Stock A, Cuda CM, Makinde HM, Perlman H, Bosanac T, Webb D, Nabozny G, Fine JS, Klein E, Ramanujam M, Putterman C.

Arthritis Res Ther. 2018 Jan 25;20(1):10. doi: 10.1186/s13075-017-1500-0.

16.

Diagnostic and prognostic tests in systemic lupus erythematosus.

Vasquez-Canizares N, Wahezi D, Putterman C.

Best Pract Res Clin Rheumatol. 2017 Jun;31(3):351-363. doi: 10.1016/j.berh.2017.10.002. Epub 2017 Nov 6. Review.

17.

Lupus Nephritis: Persistent Challenges, New Approaches.

Putterman C.

Clin Immunol. 2017 Dec;185:1-2. doi: 10.1016/j.clim.2017.05.005. No abstract available.

PMID:
29150089
18.

Novelties in the field of autoimmunity - 1st Saint Petersburg congress of autoimmunity, the bridge between east and west.

Dahan S, Segal Y, Watad A, Azrielant S, Shemer A, Maymon D, Stroev YI, Sobolevskaya PA, Korneva EA, Blank M, Gilburd B, Shovman O, Amital H, Ehrenfeld M, Tanay A, Kivity S, Pras E, Chapman J, Damoiseaux J, Cervera R, Putterman C, Shapiro I, Mouthon L, Perricone R, Bizzaro N, Koren O, Riemekasten G, Chereshnev VA, Mazurov VI, Goloviznin M, Gurevich V, Churilov LP, Shoenfeld Y.

Autoimmun Rev. 2017 Dec;16(12):1175-1184. doi: 10.1016/j.autrev.2017.10.001. Epub 2017 Oct 14. Review. No abstract available.

PMID:
29037903
19.

The Incidence and Prevalence of Systemic Lupus Erythematosus in New York County (Manhattan), New York: The Manhattan Lupus Surveillance Program.

Izmirly PM, Wan I, Sahl S, Buyon JP, Belmont HM, Salmon JE, Askanase A, Bathon JM, Geraldino-Pardilla L, Ali Y, Ginzler EM, Putterman C, Gordon C, Helmick CG, Parton H.

Arthritis Rheumatol. 2017 Oct;69(10):2006-2017. doi: 10.1002/art.40192. Epub 2017 Sep 10.

20.

Tubulointerstitial damage predicts end stage renal disease in lupus nephritis with preserved to moderately impaired renal function: A retrospective cohort study.

Broder A, Mowrey WB, Khan HN, Jovanovic B, Londono-Jimenez A, Izmirly P, Putterman C.

Semin Arthritis Rheum. 2018 Feb;47(4):545-551. doi: 10.1016/j.semarthrit.2017.07.007. Epub 2017 Jul 14.

21.

Single cell RNA sequencing to dissect the molecular heterogeneity in lupus nephritis.

Der E, Ranabothu S, Suryawanshi H, Akat KM, Clancy R, Morozov P, Kustagi M, Czuppa M, Izmirly P, Belmont HM, Wang T, Jordan N, Bornkamp N, Nwaukoni J, Martinez J, Goilav B, Buyon JP, Tuschl T, Putterman C.

JCI Insight. 2017 May 4;2(9). pii: 93009. doi: 10.1172/jci.insight.93009. [Epub ahead of print]

22.

The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface.

Stock AD, Gelb S, Pasternak O, Ben-Zvi A, Putterman C.

Autoimmun Rev. 2017 Jun;16(6):612-619. doi: 10.1016/j.autrev.2017.04.008. Epub 2017 Apr 17. Review.

23.

TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease.

Grimstad T, Skoie IM, Doerner J, Isaksen K, Karlsen L, Aabakken L, Omdal R, Putterman C.

Scand J Gastroenterol. 2017 Apr;52(4):420-424. doi: 10.1080/00365521.2016.1273382. Epub 2016 Dec 31.

PMID:
28040992
24.

New Roadmap for the Journey From Internist to Rheumatologist.

Criscione-Schreiber LG, Brown CR Jr, O'Rourke KS, Fuchs HA, Putterman C, Tan IJ, Valeriano-Marcet J, Hsieh E, Zirkle S, Bolster MB.

Arthritis Care Res (Hoboken). 2017 Jun;69(6):769-775. doi: 10.1002/acr.23151.

25.

Urinary high-mobility group box-1 associates specifically with lupus nephritis class V.

Jog NR, Blanco I, Lee I, Putterman C, Caricchio R.

Lupus. 2016 Dec;25(14):1551-1557. Epub 2016 Apr 12.

26.

Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus.

Buyon J, Furie R, Putterman C, Ramsey-Goldman R, Kalunian K, Barken D, Conklin J, Dervieux T.

Lupus Sci Med. 2016 Sep 30;3(1):e000165. eCollection 2016.

27.

International validation of a urinary biomarker panel for identification of active lupus nephritis in children.

Smith EM, Jorgensen AL, Midgley A, Oni L, Goilav B, Putterman C, Wahezi D, Rubinstein T, Ekdawy D, Corkhill R, Jones CA, Marks SD, Newland P, Pilkington C, Tullus K, Beresford MW.

Pediatr Nephrol. 2017 Feb;32(2):283-295. doi: 10.1007/s00467-016-3485-3. Epub 2016 Sep 3.

28.

CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.

Chalmers SA, Wen J, Shum J, Doerner J, Herlitz L, Putterman C.

Clin Immunol. 2017 Dec;185:100-108. doi: 10.1016/j.clim.2016.08.019. Epub 2016 Aug 26.

29.

The role of B cells and autoantibodies in neuropsychiatric lupus.

Wen J, Stock AD, Chalmers SA, Putterman C.

Autoimmun Rev. 2016 Sep;15(9):890-5. doi: 10.1016/j.autrev.2016.07.009. Epub 2016 Jul 5. Review.

30.

Fn14 deficiency protects lupus-prone mice from histological lupus erythematosus-like skin inflammation induced by ultraviolet light.

Doerner J, Chalmers SA, Friedman A, Putterman C.

Exp Dermatol. 2016 Dec;25(12):969-976. doi: 10.1111/exd.13108.

31.

Therapeutic Blockade of Immune Complex-Mediated Glomerulonephritis by Highly Selective Inhibition of Bruton's Tyrosine Kinase.

Chalmers SA, Doerner J, Bosanac T, Khalil S, Smith D, Harcken C, Dimock J, Der E, Herlitz L, Webb D, Seccareccia E, Feng D, Fine JS, Ramanujam M, Klein E, Putterman C.

Sci Rep. 2016 May 19;6:26164. doi: 10.1038/srep26164.

32.

B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.

Wen J, Doerner J, Chalmers S, Stock A, Wang H, Gullinello M, Shlomchik MJ, Putterman C.

J Neuroinflammation. 2016 Apr 7;13(1):73. doi: 10.1186/s12974-016-0537-3.

33.

Insulin-Like Growth Factor Binding Protein-4 as a Marker of Chronic Lupus Nephritis.

Wu T, Xie C, Han J, Ye Y, Singh S, Zhou J, Li Y, Ding H, Li QZ, Zhou X, Putterman C, Saxena R, Mohan C.

PLoS One. 2016 Mar 28;11(3):e0151491. doi: 10.1371/journal.pone.0151491. eCollection 2016.

34.

Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in non-autoimmune mice.

Wen J, Chen CH, Stock A, Doerner J, Gulinello M, Putterman C.

Brain Behav Immun. 2016 May;54:27-37. doi: 10.1016/j.bbi.2015.12.017. Epub 2015 Dec 23.

35.

Association between antiphospholipid antibodies and all-cause mortality among end-stage renal disease patients with and without SLE: a retrospective cohort study.

Broder A, Mowrey WB, Kim M, Murakhovskaya I, Billett H, Neugarten J, Costenbader KH, Putterman C.

Rheumatology (Oxford). 2016 May;55(5):817-25. doi: 10.1093/rheumatology/kev423. Epub 2015 Dec 24.

36.

SLE-key(®) rule-out serologic test for excluding the diagnosis of systemic lupus erythematosus: Developing the ImmunArray iCHIP(®).

Putterman C, Wu A, Reiner-Benaim A, Batty DS Jr, Sanz I, Oates J, Jakobi K, Petri M, Safer P, Gerwien R, Sorek R, Blumenstein Y, Cohen IR.

J Immunol Methods. 2016 Feb;429:1-6. doi: 10.1016/j.jim.2015.12.003. Epub 2015 Dec 8.

37.

What Is a Rheumatologist and How Do We Make One?

Brown CR Jr, Criscione-Schreiber L, O'Rourke KS, Fuchs HA, Putterman C, Tan IJ, Valeriano-Marcet J, Hsieh E, Zirkle S, Bolster MB.

Arthritis Care Res (Hoboken). 2016 Aug;68(8):1166-72. doi: 10.1002/acr.22817. Erratum in: Arthritis Care Res (Hoboken). 2016 Oct;68(10):1577.

38.

Anti-DNA antibody mediated catalysis is isotype dependent.

Xia Y, Eryilmaz E, Zhang Q, Cowburn D, Putterman C.

Mol Immunol. 2016 Jan;69:33-43. doi: 10.1016/j.molimm.2015.11.001. Epub 2015 Dec 1.

39.

The Role of Anti-DNA Antibodies in the Development of Lupus Nephritis: A Complementary, or Alternative, Viewpoint?

Goilav B, Putterman C.

Semin Nephrol. 2015 Sep;35(5):439-43. doi: 10.1016/j.semnephrol.2015.08.005. Review.

40.

Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.

Stock AD, Wen J, Doerner J, Herlitz LC, Gulinello M, Putterman C.

J Neuroinflammation. 2015 Nov 6;12:205. doi: 10.1186/s12974-015-0423-4.

41.

A peptide mimic blocks the cross-reaction of anti-DNA antibodies with glomerular antigens.

Xia Y, Eryilmaz E, Der E, Pawar RD, Guo X, Cowburn D, Putterman C.

Clin Exp Immunol. 2016 Mar;183(3):369-79. doi: 10.1111/cei.12734. Epub 2015 Dec 8.

42.

Therapeutic targeting of macrophages in lupus nephritis.

Chalmers SA, Chitu V, Ramanujam M, Putterman C.

Discov Med. 2015 Jul-Aug;20(108):43-9. Review.

43.

Extracellular RNAs: development as biomarkers of human disease.

Quinn JF, Patel T, Wong D, Das S, Freedman JE, Laurent LC, Carter BS, Hochberg F, Van Keuren-Jensen K, Huentelman M, Spetzler R, Kalani MY, Arango J, Adelson PD, Weiner HL, Gandhi R, Goilav B, Putterman C, Saugstad JA.

J Extracell Vesicles. 2015 Aug 28;4:27495. doi: 10.3402/jev.v4.27495. eCollection 2015.

44.

Biomarkers for CNS involvement in pediatric lupus.

Rubinstein TB, Putterman C, Goilav B.

Biomark Med. 2015;9(6):545-58. doi: 10.2217/bmm.15.26. Review.

45.

Biomarkers for kidney involvement in pediatric lupus.

Goilav B, Putterman C, Rubinstein TB.

Biomark Med. 2015;9(6):529-43. doi: 10.2217/bmm.15.25. Review.

46.

Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis.

Seret G, Cañas F, Pougnet-Di Costanzo L, Hanrotel-Saliou C, Jousse-Joulin S, Le Meur Y, Saraux A, Valeri A, Putterman C, Youinou P, Rojas-Villarraga A, Anaya JM, Renaudineau Y.

J Autoimmun. 2015 Jul;61:54-61. doi: 10.1016/j.jaut.2015.05.009. Epub 2015 Jun 10.

PMID:
26071203
47.

Differential Development of Systemic Lupus Erythematosus in NZM 2328 Mice Deficient in Discrete Pairs of BAFF Receptors.

Jacob CO, Yu N, Sindhava V, Cancro MP, Pawar RD, Putterman C, Stohl W.

Arthritis Rheumatol. 2015 Sep;67(9):2523-35. doi: 10.1002/art.39210.

48.

TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice.

Wen J, Doerner J, Weidenheim K, Xia Y, Stock A, Michaelson JS, Baruch K, Deczkowska A, Gulinello M, Schwartz M, Burkly LC, Putterman C.

J Autoimmun. 2015 Jun;60:40-50. doi: 10.1016/j.jaut.2015.03.005. Epub 2015 Apr 22.

49.

TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus.

Doerner JL, Wen J, Xia Y, Paz KB, Schairer D, Wu L, Chalmers SA, Izmirly P, Michaelson JS, Burkly LC, Friedman AJ, Putterman C.

J Invest Dermatol. 2015 Aug;135(8):1986-1995. doi: 10.1038/jid.2015.124. Epub 2015 Mar 31.

50.

Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.

Mohan C, Putterman C.

Nat Rev Nephrol. 2015 Jun;11(6):329-41. doi: 10.1038/nrneph.2015.33. Epub 2015 Mar 31. Review.

PMID:
25825084

Supplemental Content

Loading ...
Support Center